Who is sponsoring NCT06090942?

NCT06090942 is sponsored by Taipei Medical University.

What drugs are being tested in NCT06090942?

Interventions in NCT06090942: Smartphone-based cognitive training.

What condition does NCT06090942 study?

NCT06090942 studies Cognitive Decline, Healthy Aging.

Is NCT06090942 still recruiting?

NCT06090942 is currently status unknown. Last updated 19 October 2023.

Last reviewed 2023-10-19 · How we verify

NCT06090942

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Cognitive Training for Digital Biomarkers

Status unknown NA Last updated 19 October 2023

What this trial tests

NA trial testing Smartphone-based cognitive training in Cognitive Decline in 90 participants. Status unknown.

Timeline

20 October 2023

Primary endpoint
31 July 2024

31 July 2024

Quick facts

Lead sponsor	Taipei Medical University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	diagnostic
Enrollment	90
Start date	20 October 2023
Primary completion	31 July 2024
Estimated completion	31 July 2024

Drugs / interventions tested

Smartphone-based cognitive training

Conditions studied

Cognitive Decline — all drugs for Cognitive Decline →
Healthy Aging — all drugs for Healthy Aging →

Sponsor

Taipei Medical University

Who can join

Adults 60 to 95, any sex, with Cognitive Decline or Healthy Aging. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to conduct cognitive training for digital biomarkers among older adults.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Cognitive Decline

Currently open trials in the same condition.

NCT07220694 — Effects of Sabroxy® Supplementation on Insulin Resistance and Cognitive Function in Adults With Mild Cognitive Impairmen · NA · recruiting
NCT07394504 — Effects of Turning Based Dual Task Training on Balance and Mild Cognitive Impairment in Diabetic Peripheral Neuropathy · NA · recruiting
NCT07127965 — Exercise Adherence and Cognitive Decline: Phase 2 · NA · recruiting
NCT07151365 — Plant-based Diets and Healthy Aging · recruiting
NCT07399418 — TRIAD - Tracking Risk in Integrated Alzheimer's Diagnostics. · recruiting

Other Taipei Medical University trials

Trials by the same sponsor.

NCT07496658 — Nutritional Status, Nutritional Knowledge and Mental Health Among Indonesian Migrant Workers in Taiwan · not yet recruiting
NCT06930313 — Compassion-Based Intervention for Lung Cancer Caregivers (CBI-LCC) · NA · not yet recruiting
NCT07349446 — Effects of Circadian-Based Acupressure on Sleep Quality in Nursing Home Residents · NA · not yet recruiting
NCT07259369 — The Effects of an App-based Acupressure on Alleviating Fatigue, Pruritus, and Sleep Quality Among Hemodialysis Patients · NA · not yet recruiting
NCT07275372 — Using Virtual Humans to Teach Cognitive Function Assessment to Nursing Students · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06090942 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Taipei Medical University
Last refreshed: 19 October 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06090942.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing